Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
1,884,557,887 shares speaks volume more than the people saying it will dump!
Break 0.019 and off to the races!!! :)
Mr. Burckhardt has been instrumental in several transactions, some of which were the result of Reverse Mergers
BOOM! THOMAS JASPERS
Check https://www.qestco.com/firm
Rules for O.T.C! Follow the volume and make money! :)
This is not just retail!!!!!!!!!!
WOW this is either some serious retail or more likely some big players coming in!
Part of the email I received from management stating their future intentions "the blends we will be manufacturing and distributing in NA is http://speco.sg and can also find info on our geniebrands site soon at www.megolacorp.com and goto genie brands tab. Just getting blends registered with EPA.FDA,Health Canada etc" Looks like they will be the North American manufacture and distributor of Speco
You want it to run just pay the notes off!
We shall see :)
0.008 Sorry
"Tautachrome, Inc., today executed a collaborative agreement with Boston University Radiology Associates and Honeycomb Archive, LLC to research, develop and prototype innovations in virtual radiology education using the ARknet mobile platform app. Included in the scope of this collaboration for the advancement of radiology training is the discovery and blueprinting of the use of interactive augmented reality, the use of integrated video meetups in learning management and the use of Tautachrome patented trusted imagery tracking technology. All parties retain an interest in future commercialization and follow-on funding opportunities."
THE MM's know they can't let it pass the PPS 0f $0.08 or will run. Kind of oblivious from the three walls put up today :)
Sorry stock buying is not about where it has been but where it is going and I only referring to short term here with the chart. I m not saying it has been a positive or good looking chart in the past rather about where it is going in the short term future! Good luck to you $TTCM p.s I have been a while as well :)
You will not have to wait long!$TTCM
Yee of little faith, just watch over the next few days! Magic :) $TTCM
All right I bit, I took a starter position!
Been following the last couple of weeks. Looking like it maybe close to time to pull the trigger. Strange that they start this morning off by putting up a fake wall to begin the morning. Will be watching and ready to pull the trigger.
Can someone please confirm the number of floating shares. Seems to be a really low amount. Thanks
The volume of conversation both negative and positive tend to tell you that something is up here because the death of a stock is the lack of interest! As long you have a little risk to volatility seems like a pretty good bet here! $SBFM
MONDAY WILL BE HAPPY HOUR!
FDA News Release
Coronavirus (COVID-19) Update: Daily RoundupJuly 23, 2020
The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
Today, the FDA updated the Testing Supply Substitution Strategies slide show. This presentation includes validated supply alternatives that labs can use to continue performing testing when there is a supply issue with some components of a molecular test.
This week, FDA and the Federal Trade Commission issued a joint warning letter to 21st Century LaserMed Pain & Regenerative Medicine Institute (d/b/a Create Wellness Clinics) for offering unapproved, unlicensed, uncleared and unauthorized products for the mitigation, prevention, treatment, diagnosis or cure of COVID-19. There are currently no FDA-approved products to prevent or treat COVID-19. Consumers concerned about COVID-19 should consult with their health care provider.
Testing updates:
To date, the FDA has currently authorized 187 tests under EUAs; these include 154 molecular tests, 31 antibody tests, and 2 antigen tests.
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-july-23-2020
COMMON SENSE! Wait till FDA approval hits, wait till news on cancer treatment. The CEO is amongst the top 5 scientist in the WORLD and gave these patents to SBFM
WELL TAKE A LOOK! Anticancer compound is Adva-27a, a GEM-difluorinated C-glycoside derivative of Podophyllotoxin
https://pubmed.ncbi.nlm.nih.gov/23060568/
Due the Math! :
The patent application has a priority date of May 22, 2020
http://sunshinebiopharma.com/assets/press/SBFM%20Press%20Release%20June%203,%202020_Coronavirus%20Patent.pdf
YES SIR!
SBFM acquires licensing for Finasteride, Letrozole, Bicalutamide & Anastrozole.
sunshinebiopharma.com/drugs-market.html
Anastrozole for treatment of Breast Cancer.
Letrozole for treatment of Breast Cancer.
Bicalutamide for treatment of Prostate Cancer.
Finasteride for treatment of BPH (Benign Prostatic Hyperplasia)
Sunshine Biopharma's four new generic products together with the previously announced initial generic product are as follows:
Anastrozole (brand name Arimidex® by AstraZenica) for treatment of Breast Cancer
Letrozole (brand name Femara® by Novartis) for treatment of Breast Cancer
Bicalutamide (brand name Casodex® by AstraZenica) for treatment of Prostate Cancer
Finasteride (brand name Propecia® by Merck) for treatment of BPH (Benign Prostatic Hyperplasia)
SBFM has developed, patented, and have begun trials for adva-27a, a cancer fighting injectable solution.
SBFM filed for a patent extension, granting full rights to adva-27a, until 1-2034. That includes everything, licensing, manufacturing & distribution of adva-27a
https://patents.google.com/patent/US20150353573/en
Adva-27a is effective at killing different types of multidrug resistant cancer cells, including:
Breast Cancer Cells (MCF-7/MDR)
Small Cell Lung Cancer Cells (H69AR)
Uterine Cancer (MES-SA/Dx5)
Pancreatic Cancer (Panc-1)
Adva-27a is unaffected by P-Glycoprotein, the enzyme responsible for making cancer cells resistant to anti-tumor drugs.
Adva-27a has excellent clearance time (half-life = 54 minutes) as indicated by human microsomes stability studies and pharmacokinetics data in rats.
Adva-27a clearance is independent of Cytochrome P450, a mechanism that is less likely to produce toxic intermediates.
Adva-27a is an excellent inhibitor of Topoisomerase II with an IC50 of only 13.7 micromolar (this number has recently been reduce to 1.44 micromolar as a result of resolving the two isomeric forms of Adva-27a).
Adva-27a has shown excellent pharmacokinetics profile as indicated by studies done in rats.
Adva-27a does not inhibit tubulin assembly.
List of patents (one additional pending!!)
Patent: 10,272,065
Reassignment Date: 2019-02-27
Current Assignee: Sunshine Biopharma Inc
Owner name: SUNSHINE BIOPHARMA INC., CANADA
Effective Date: 20190226
Status: Active
Anticipated Expiration: 2034-01-13
Patent: 8,236,935
Reassignment Date: 2019-02-27
Current Assignee: Sunshine Biopharma Inc
Owner name: SUNSHINE BIOPHARMA INC., CANADA
Effective date: 20190226
Status: Active
Anticipated Expiration: 2028-11-07
Time to buy because you now know there will be a 10 Q coming
Check 52 week range :)
https://ca.finance.yahoo.com/quote/SBFM?p=SBFM&.tsrc=fin-srch
Shares Outstanding 112.889M
Number of Floating Shares 101.447M
Let the GAMES begin today!
52 Week High 0.9445
Yes you want guarantee's in the OTC, really!
60 million @8
All Buys in in the last 20 mins
Yes people are always looking for the easy way and chase and too scared to buy and hold for more than a day.
They are holding it down to buy more before next PR
I think I may take a little nibble here as volume and risk reward here looks good. Shall see :)